Collectively, these results demonstrate that fenofibrate activates PPARα and its downstream targets involved in lipogenesis in the liver to ameliorate the impaired lipid metabolism induced by LIF overexpression in TgLC mice and C26 tumor-bearing mice, which in turn inhibits cachexia development (Fig. 6K). Here, LIF is linked to neoplasm.